Humalog Junior KwikPen Interactions
There are 396 drugs known to interact with Humalog Junior KwikPen (insulin lispro), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 16 are major, 359 are moderate, and 21 are minor.
- View all 396 medications that may interact with Humalog Junior KwikPen
- View Humalog Junior KwikPen alcohol/food interactions (1)
- View Humalog Junior KwikPen disease interactions (3)
Most frequently checked interactions
View interaction reports for Humalog Junior KwikPen (insulin lispro) and the medicines listed below.
- acyclovir
- albuterol
- aspirin
- atorvastatin
- baclofen
- budesonide
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- duloxetine
- Eliquis (apixaban)
- fenofibrate
- Flomax (tamsulosin)
- Flonase (fluticasone nasal)
- gabapentin
- glimepiride
- Humalog Mix 50/50 KwikPen (insulin lispro/insulin lispro protamine)
- Humalog Mix 75/25 KwikPen (insulin lispro/insulin lispro protamine)
- hydroxyzine
- Januvia (sitagliptin)
- Jardiance (empagliflozin)
- Lantus (insulin glargine)
- Lantus SoloStar (insulin glargine)
- Levemir (insulin detemir)
- levothyroxine
- lisinopril
- Metoprolol Tartrate (metoprolol)
- ProAir HFA (albuterol)
- trazodone
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Humalog Junior KwikPen alcohol/food interactions
There is 1 alcohol/food interaction with Humalog Junior KwikPen (insulin lispro).
Humalog Junior KwikPen disease interactions
There are 3 disease interactions with Humalog Junior KwikPen (insulin lispro) which include:
Report options
QR code containing a link to this page
More about Humalog Junior KwikPen (insulin lispro)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: insulin
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
